OMX Nordic 40
2.369,49
PKT
-15,60
PKT
-0,65
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.05.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 23.05.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 22.05.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 21.05.25 | Hennes Mauritz (H M, H&M) Equal Weight | Barclays Capital | |
| 20.05.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 20.05.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 19.05.25 | Novo Nordisk Buy | UBS AG | |
| 19.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.05.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.05.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.05.25 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Volvo (B) Underperform | Bernstein Research | |
| 12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 09.05.25 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
| 09.05.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 09.05.25 | Novo Nordisk Buy | UBS AG | |
| 08.05.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 08.05.25 | Novo Nordisk Halten | DZ BANK | |
| 08.05.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | UBS AG | |
| 07.05.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.05.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.05.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | AstraZeneca Halten | DZ BANK | |
| 30.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG |